Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - An animal model of smallpoxPARKER, Scott; CHEN, Nanhai G; SAGARTZ, John E et al.Antiviral research. 2012, Vol 94, Num 1, pp 44-53, issn 0166-3542, 10 p.Article

Clinically validated genotype analysis: guiding principles and statistical concernsBRUN-VEZINET, Francoise; COSTAGLIOLA, Dominique; LANIER, Randall et al.Antiviral therapy (London). 2004, Vol 9, Num 4, pp 465-478, issn 1359-6535, 14 p.Article

A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infectionCOULL, Jason J; TURNER, Diana; MELBY, Thomas et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 26, Num 5, pp 423-434, issn 1525-4135Article

Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine and Tenofovir DF (Study COL40263)ROSS, Lisa; ELION, Richard; BELINDA HA et al.AIDS research and human retroviruses. 2009, Vol 25, Num 7, pp 665-672, issn 0889-2229, 8 p.Article

Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001PARKER, Scott; SCHRIEWER, Jill; OBERLE, Christina et al.Antiviral therapy (London). 2008, Vol 13, Num 7, pp 863-873, issn 1359-6535, 11 p.Article